homehome2menu22linkedin22facebook2twitter2google-plussearch2triangle-righttriangle-leftbubble22bubble2bubblesdrawerhistorystats-barsfeed2file-emptycheckmark2infochevron-with-circle-right
Menu Job Search

Showing posts from July 2012

Routes Healthcare - Growing out of the Economic Downturn

From Monday 6 August, Routes Healthcare will have a new Macclesfield office to service our South Cheshire and Derbyshire clients and staff which will also be our new Accounts and Payroll base. 

This expansion will not only give us a dedicated presence in this region of the country enabling us to provide an even more efficient and speedy service, it has also allowed Routes to create two new job vacancies as we seek to increase our Central Services and Accounts staffing.

Please see the Central Services and Macclesfield sections on the Contacts page for details of our new phone and fax numbers.

Posted by: Andrew Healing on July 31st, 2012 @ 10:48 PM

Routes Healthcare Supporting the Local Community

Routes Healthcare is acting as one of the local companies to sponsor and support Rathmell Young Farmers in Craven, North Yorkshire for its up and coming Rathmell Show, near Settle.

#supportinglocalruralbusiness

Posted by: Andrew Healing on July 24th, 2012 @ 09:56 AM

Is there a future for luxury care homes?

The not-for-profit group Anchor, best known for its sheltered housing, is opening a luxury care home. The charity believes it marks the start of a new model of care for the baby boomer generation. But with doubts remaining about the future prospects for sector will the approach take off?

Set in five acres of Surrey greenbelt, West Hall is not the average care home.

The £30m development has 117 en-suite rooms, a hair salon, a library, landscaped gardens and a private dining room for special occasions.

The accommodation is housed in three separate purpose-built buildings, known as "clusters", while many of the communal facilities are situated in a listed manor house.

The rooms are all equipped with sensors which alert staff if someone has fallen or stopped moving and each area in the clusters is coloured differently to help those with advanced dementia recognise their living areas.

But what also marks the centre out is the level of training everyone has. There is a 12-week induction that covers dementia care which all staff, from the care professionals to the handyman, complete.

View the original article here.

 

 

 

Posted by: on July 23rd, 2012 @ 1:42 PM

Donate to 'Pilgrim Bandits'

We would like to wish Maria Gidman all the best for her part in attempting to break the world record for the number of tandem parachute jumps in one day - all for a good cause to support the charity 'Pilgrim Bandits', raising funds for forces amputees and local veterans. 

You can donate on Maria's JustGiving page ...

http://www.justgiving.com/Maria-Gidman

Posted by: on July 23rd, 2012 @ 1:08 PM

Cancer 'Smart Bomb' Successfully Tested in US

Scientists have successfully tested a capillary "smart bomb" that simultaneously attacks cancer and boosts the immune system.

The tiny hollow spheres become trapped in leaky tumour blood vessels, where they unleash an anti-cancer drug.

At the same time the spheres, called nanolipogels (NLGs), release a protein that rallies the body's own defences.

Researchers tested the spheres in mice on melanoma skin cancer that had spread to the lungs.

Tumour growth was significantly delayed and the survival of the mice increased.

The new technology overcomes a problem with cancer treatment that has been difficult to tackle using conventional therapies, say the scientists.

Cancer tumours are known to secrete chemicals that confuse the immune system.

But attempts to boost patient immunity while at the same time neutralising the cancer's chemical arsenal rarely work.

The NLGs, described in the journal Nature Materials, package together two completely different kinds of molecule.

One is designed to overcome a potent cancer defence weapon called TGF-beta, which stunts the local immune system.

The other, an interleukin signalling molecule, boosts immune system activity.

Researcher Dr Stephen Wrzesinski, from Yale University School of Medicine in the US, said: "One problem with current metastatic (spreading) melanoma immunotherapies is the difficulty managing autoimmune toxicities when the treatment agents are administered throughout the body.

"The novel nanolipogel delivery system we used will hopefully bypass systemic toxicities while providing support to enable the body to fight off the tumour at the tumour bed itself."

Each NLG is small enough to travel through the bloodstream, but large enough to get entrapped in leaky cancer blood vessels. Once trapped, they biodegrade to release their cargo.

Article taken from Sky News - click here to view.

Posted by: on July 16th, 2012 @ 12:52 AM

Choose a page:
1 2 3

LinkedIn Twitter Facebook